Increased iNOS activity in vascular smooth muscle cells from diabetic rats: Potential role of Ca2+/calmodulin-dependent protein kinase II delta 2 (CaMKIIδ2)

Atherosclerosis

Volumn 226, Issue 1, 2013, Pages 88-94

  Di Pietro, Natalia ^a   Di Tomo, Pamela ^a   Di Silvestre, Sara ^a   Giardinelli, Annalisa ^a   Pipino, Caterina ^a   Morabito, Caterina ^a   Formoso, Gloria ^a   Mariggiò, Maria Addolorata ^a   Pandolfi, Assunta ^a  

^a UNIVERSITY OF CHIETI   (Italy)

Author keywords

Ca2+ calmodulin dependent protein kinase II; Diabetes; Inducible nitric oxide synthase; Nitrotyrosine; Vascular smooth muscle cells

Indexed keywords

3 NITROTYROSINE; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II DELYA 2; CALCIUM ION; INDUCIBLE NITRIC OXIDE SYNTHASE; LIPOPOLYSACCHARIDE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; IMMUNOFLUORESCENCE; IMMUNOPRECIPITATION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE; VASCULAR SMOOTH MUSCLE CELL; WESTERN BLOTTING;

ANIMALS; CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASE TYPE 2; DIABETES MELLITUS, EXPERIMENTAL; MALE; MUSCLE, SMOOTH, VASCULAR; NITRIC OXIDE SYNTHASE TYPE II; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84871395612     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2012.10.062     Document Type: Article

References (30)

1. Farrag A., Bakhoum S., Salem M.A., El-Faramawy A., Gergis E. The association between extracoronary calcification and coronary artery disease in patients with type 2 diabetes mellitus. Heart Vessels 2011 Nov 3, [Epub ahead of print].
2. Kawano N., Emoto M., Mori K., et al. Association of endothelial and vascular smooth muscle dysfunction with cardiovascular risk factors, vascular complications, and subclinical carotid atherosclerosis in type 2 diabetic patients. J Atheroscler Thromb 2011, 19(3):276-284.
3. Szabo C. Role of nitrosative stress in the pathogenesis of diabetic vascular dysfunction. Br J Pharmacol 2009, 156:713-727.
4. Mohan S., Konopinski R., Yan B., Centonze V.E., Natarajan M. High glucose-induced IKK-Hsp-90 interaction contributes to endothelial dysfunction. Am J Physiol Cell Physiol 2009, 296:C182-C192.
5. Jarvisalo M.J., Raitakari M., Toikka J.O., et al. Endothelial dysfunction and increased arterial intima-media thickness in children with type 1 diabetes. Circulation 2004, 109:1750-1755.
6. van den Oever I.A., Raterman H.G., Nurmohamed M.T., Simsek S. Endothelial dysfunction, inflammation, and apoptosis in diabetes mellitus. Mediators Inflamm 2010, 2010:792393.
7. Forstermann U., Sessa W.C. Nitric oxide synthases: regulation and function. Eur Heart J 2012, 33:829-837.
8. Li H., Forstermann U. Nitric oxide in the pathogenesis of vascular disease. J Pathol 2000, 190:244-254.
9. Yang J., Clark J.W., Bryan R.M., Robertson C.S. Mathematical modeling of the nitric oxide/cGMP pathway in the vascular smooth muscle cell. Am J Physiol Heart Circ Physiol 2005, 289:H886-H897.
10. Pandolfi A., De Filippis E.A. Chronic hyperglicemia and nitric oxide bioavailability play a pivotal role in pro-atherogenic vascular modifications. Genes Nutr 2007, 2:195-208.
11. Buchwalow I.B., Podzuweit T., Bocker W., et al. Vascular smooth muscle and nitric oxide synthase. Faseb J 2002, 16:500-508.
12. Pandolfi A., Grilli A., Cilli C., et al. Phenotype modulation in cultures of vascular smooth muscle cells from diabetic rats: association with increased nitric oxide synthase expression and superoxide anion generation. J Cell Physiol 2003, 196:378-385.
13. Soskic S.S., Dobutovic B.D., Sudar E.M., et al. Regulation of inducible nitric oxide synthase (iNOS) and its potential role in insulin resistance, diabetes and heart failure. Open Cardiovasc Med J 2011, 5:153-163.
14. Perrotta I, Brunelli E, Sciangula A, Conforti F, Perrotta E, Tripepi S, et al. iNOS induction and PARP-1 activation in human atherosclerotic lesions: an immunohistochemical and ultrastructural approach. Cardiovasc Pathol;20:195-203.
15. Szabo C., Mabley J.G., Moeller S.M., et al. Part I: pathogenetic role of peroxynitrite in the development of diabetes and diabetic vascular complications: studies with FP15, a novel potent peroxynitrite decomposition catalyst. Mol Med 2002, 8:571-580.
16. Pradhan A.D., Manson J.E., Rifai N., Buring J.E., Ridker P.M. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. J Am Med Assoc 2001, 286:327-334.
17. Nagareddy P.R., Xia Z., McNeill J.H., MacLeod K.M. Increased expression of iNOS is associated with endothelial dysfunction and impaired pressor responsiveness in streptozotocin-induced diabetes. Am J Physiol Heart Circ Physiol 2005, 289:H2144-H2152.
18. Kolodziejska K.E., Burns A.R., Moore R.H., Stenoien D.L., Eissa N.T. Regulation of inducible nitric oxide synthase by aggresome formation. Proc Natl Acad Sci U S A 2005, 102:4854-4859.
19. Jones R.J., Jourd'heuil D., Salerno J.C., Smith S.M., Singer H.A. iNOS regulation by calcium/calmodulin-dependent protein kinase II in vascular smooth muscle. Am J Physiol Heart Circ Physiol 2007, 292:H2634-H2642.
20. Hudmon A., Schulman H. Structure-function of the multifunctional Ca2+/calmodulin-dependent protein kinase II. Biochem J 2002, 364:593-611.
21. Yousif M.H., Akhtar S., Walther T., Benter I.F. Role of Ca2+/calmodulin-dependent protein kinase II in development of vascular dysfunction in diabetic rats with hypertension. Cell Biochem Funct 2008, 26:256-263.
22. Pfleiderer P.J., Lu K.K., Crow M.T., Keller R.S., Singer H.A. Modulation of vascular smooth muscle cell migration by calcium/calmodulin-dependent protein kinase II-delta 2. Am J Physiol Cell Physiol 2004, 286:C1238-C1245.
23. Foglia V. Caracteristicas de la diabetes en la rata. Rev Soc Argent Biol 1944, 20:21-34.
24. Morabito C., Bosco G., Pilla R., et al. Effect of pre-breathing oxygen at different depth on oxidative status and calcium concentration in lymphocytes of scuba divers. Acta Physiol (Oxf) 2011, 202:69-78.
25. Wilkinson M.F., Earle M.L., Triggle C.R., Barnes S. Interleukin-1beta, tumor necrosis factor-alpha, and LPS enhance calcium channel current in isolated vascular smooth muscle cells of rat tail artery. Faseb J 1996, 10:785-791.
26. Villeneuve L.M., Natarajan R. The role of epigenetics in the pathology of diabetic complications. Am J Physiol Ren Physiol 2010, 299:F14-F25.
27. Li S.L., Reddy M.A., Cai Q., et al. Enhanced proatherogenic responses in macrophages and vascular smooth muscle cells derived from diabetic db/db mice. Diabetes 2006, 55:2611-2619.
28. Dunn K.M., Nelson M.T. Calcium and diabetic vascular dysfunction. Focus on " Elevated Ca(2+) sparklet activity during acute hyperglycemia and diabetes in cerebral arterial smooth muscle cells" Am J Physiol Cell Physiol 2010, 298:C203-C205.
29. Camici G.G., Schiavoni M., Francia P., et al. Genetic deletion of p66(Shc) adaptor protein prevents hyperglycemia-induced endothelial dysfunction and oxidative stress. Proc Natl Acad Sci U S A 2007, 104:5217-5222.
30. Pacher P., Beckman J.S., Liaudet L. Nitric oxide and peroxynitrite in health and disease. Physiol Rev 2007, 87:315-424.